Patents by Inventor Ann R. Kennedy

Ann R. Kennedy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of BBI/BBIC for treatment of muscular atrophy and degenerative muscle disease
    Patent number: 8852650
    Abstract: Methods for use of a composition comprising Bowman-Birk Inhibitor (BBI) or a derivative thereof in the treatment and/or prevention of skeletal muscle atrophy, to improve of skeletal muscle function, and to alleviate symptoms and/or slow progression of degenerative skeletal muscle diseases or disorders are provided.
    Type: Grant
    Filed: August 17, 2011
    Date of Patent: October 7, 2014
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: H. Lee Sweeney, Carl A. Morris, Ann R. Kennedy
  • Use of BBI/BBIC for Treatment of Muscular Atrophy and Degenerative Muscle Disease
    Publication number: 20110301075
    Abstract: Methods for use of a composition comprising Bowman-Birk Inhibitor (BBI) or a derivative thereof in the treatment and/or prevention of skeletal muscle atrophy, to improve of skeletal muscle function, and to alleviate symptoms and/or slow progression of degenerative skeletal muscle diseases or disorders are provided.
    Type: Application
    Filed: August 17, 2011
    Publication date: December 8, 2011
    Applicant: The Trustees of the University of Pennsylvania
    Inventors: H. Lee Sweeney, Carl A. Morris, Ann R. Kennedy
  • Bowman-Birk Inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease
    Patent number: 8017161
    Abstract: Methods for use of a composition comprising Bowman-Birk Inhibitor (BBI) or a derivative thereof in the treatment and/or prevention of skeletal muscle atrophy, to improve of skeletal muscle function, and to alleviate symptoms and/or slow progression of degenerative skeletal muscle diseases or disorders are provided.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: September 13, 2011
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: H. Lee Sweeney, Carl A. Morris, Ann R. Kennedy
  • Bowman-Birk Inhibitor Compositions for Treatment of Muscular Atrophy and Degenerative Muscle Disease
    Publication number: 20080300179
    Abstract: Methods for use of a composition comprising Bowman-Birk Inhibitor (BBI) or a derivative thereof in the treatment and/or prevention of skeletal muscle atrophy, to improve of skeletal muscle function, and to alleviate symptoms and/or slow progression of degenerative skeletal muscle diseases or disorders are provided.
    Type: Application
    Filed: July 30, 2004
    Publication date: December 4, 2008
    Applicant: The Trustees of the University of Pennsylvania
    Inventors: H. Lee Sweeney, Carl A. Morris, Ann R. Kennedy
  • Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases
    Patent number: 6767564
    Abstract: The present invention provides a non-toxic therapy and a novel use for Bowman Birk Inhibitor (BBI), as administered in Bowman Birk Inhibitor Concentrate (BBIC), for the treatment of autoimmune diseases in a patient, wherein the disease is characterized by chronic inflammation, such as rheumatoid arthritis; and more particularly for the treatment of those diseases that are characterized by chronic neuroinflammation and/or demyelination, such as Multiple Sclerosis (MS) and Guillain Barre Syndrome (GBS). In addition, the present invention provides methods for using BBI/BBIC to reduce, inhibit, suppress or prevent the chronic inflammation in such patients; and more particularly, to reduce, inhibit, suppress or prevent the chronic neuroinflammation and demyelination that occurs when the patient's nerve tissue is affected by the disease.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: July 27, 2004
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Abdolmohamad Rostami, Ann R. Kennedy
  • Use of Bowman Birk Inhibitor for the treatment of multiple sclerosis and other autoimmune diseases
    Publication number: 20040142050
    Abstract: The present invention provides a non-toxic therapy and a novel use for Bowman Birk Inhibitor (BBI), as administered in Bowman Birk Inhibitor Concentrate (BBIC), for the treatment of autoimmune diseases in a patient, wherein the disease is characterized by chronic inflammation, such as rheumatoid arthritis; and more particularly for the treatment of those diseases that are characterized by chronic neuroinflammation and/or demyelination, such as Multiple Sclerosis (MS) and Guillain Barre Syndrome (GBS). In addition, the present invention provides methods for using BBI/BBIC to reduce, inhibit, suppress or prevent the chronic inflammation in such patients; and more particularly, to reduce, inhibit, suppress or prevent the chronic neuroinflammation and demyelination that occurs when the patient's nerve tissues is affected by the disease.
    Type: Application
    Filed: December 22, 2003
    Publication date: July 22, 2004
    Inventors: Abdolmohamad Rostami, Ann R. Kennedy
  • Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases
    Publication number: 20020127289
    Abstract: The present invention provides a non-toxic therapy and a novel use for Bowman Birk Inhibitor (BBI), as administered in Bowman Birk Inhibitor Concentrate (BBIC), for the treatment of autoimmune diseases in a patient, wherein the disease is characterized by chronic inflammation, such as rheumatoid arthritis; and more particularly for the treatment of those diseases that are characterized by chronic neuroinflammation and/or demyelination, such as Multiple Sclerosis (MS) and Guillain Barre Syndrome (GBS). In addition, the present invention provides methods for using BBI/BBIC to reduce, inhibit, suppress or prevent the chronic inflammation in such patients; and more particularly, to reduce, inhibit, suppress or prevent the chronic neuroinflammation and demyelination that occurs when the patient's nerve tissue is affected by the disease.
    Type: Application
    Filed: August 31, 2001
    Publication date: September 12, 2002
    Applicant: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: Abdolmohamad Rostami, Ann R. Kennedy
  • Bowman-birk inhibitor compositions and methods for the treatment of genitourinary diseases
    Patent number: 5961980
    Abstract: A composition containing a Bowman Birk Inhibitor and a pharmaceutically acceptable carrier are provided for treatment of genitourinary tract diseases relating to smooth muscle contraction leading to urinary symptoms and male sexual dysfunction or atypical prostate cells. Methods of using these compositions in treatment of these diseases are also provided.
    Type: Grant
    Filed: January 18, 1996
    Date of Patent: October 5, 1999
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Ann R. Kennedy, Larry Clark
  • Method of monitoring exposure to Bowman Birk inhibitor using monoclonal antibodies against Bowman Birk inhibitor metabolites
    Patent number: 5618679
    Abstract: Monoclonal antibodies and a method capable of detecting Bowman Birk inhibitor metabolites in a sample of body fluid or tissue are provided.
    Type: Grant
    Filed: December 19, 1994
    Date of Patent: April 8, 1997
    Assignees: Trustees of the University of Pennsylvania, University of Rochester
    Inventors: Ann R. Kennedy, Cameron J. Koch, Edith M. Lord, Xingsheng Wan
  • Monoclonal antibodies differentially reactive with native and reductively modified Bowman-Birk protease inhibitor
    Patent number: 5616492
    Abstract: Monoclonal antibodies and a method capable of detecting BBI metabolites in a sample of body fluid or tissue are provided.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: April 1, 1997
    Assignees: Trustees of the University of Pennsylvania, University of Rochester
    Inventors: Ann R. Kennedy, Cameron J. Koch, Edith M. Lord, Xingsheng Wan
  • Bowman-Birk Inhibitor compositions for treatment of inflammatory disease
    Patent number: 5614198
    Abstract: A composition containing a Bowman-Birk Inhibitor for the treatment of inflammation is provided. Methods of using this composition in the treatment of IBD and hepatic inflammation are also provided.
    Type: Grant
    Filed: July 25, 1995
    Date of Patent: March 25, 1997
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Ann R. Kennedy, Paul C. Billings
  • Bowman-birk inhibitor concentrate compositions and methods for the treatment of pre-malignant tissue
    Patent number: 5505946
    Abstract: A composition containing a Bowman-Birk Inhibitor Concentrate (BBIC) for the treatment of pre-malignant tissue is provided. Methods of using this composition in the prevention of cancer are also provided.
    Type: Grant
    Filed: April 1, 1994
    Date of Patent: April 9, 1996
    Assignees: Trustees of Univ of PA, Central Soya Co, Inc.
    Inventors: Ann R. Kennedy, Bernard F. Szuhaj
  • Method of inhibiting radiation induced weight and hair loss
    Patent number: 5376373
    Abstract: Methods for inhibiting radiation induced weight and hair loss are provided. A Bowman Birk Inhibitor product is administered in an effective amount, preferably orally, to inhibit cutaneous manifestations of radiation and weight loss.
    Type: Grant
    Filed: March 11, 1993
    Date of Patent: December 27, 1994
    Assignees: Trustees of the University of Pennsylvania, Central Soya Co., Inc.
    Inventors: Ann R. Kennedy, Bernard F. Szuhaj
  • Bowman-Birk inhibitor product for use as an anticarcinogenesis agent
    Patent number: 5338547
    Abstract: Methods for the suppression and inhibition of carcinogenesis are provided in which a Bowman-Birk product produced in accordance with the processes described are administered. The methods are particularly adaptable to the prevention or treatment of colon, lung, liver, esophagus, oral epithelium (squamous carcinomas), and bone marrow cancer. The preferred mode of administration is as a dietary supplement.
    Type: Grant
    Filed: November 2, 1992
    Date of Patent: August 16, 1994
    Assignees: Trustees of the Univ. of Pennsylvania, Central Soya
    Inventors: Ann R. Kennedy, Bernard F. Szuhaj
  • Method of making soybean Bowman-Birk inhibitor concentrate and use of same as a human cancer preventative and therapy
    Patent number: 5217717
    Type: Grant
    Filed: January 17, 1992
    Date of Patent: June 8, 1993
    Assignees: Central Soya Company, Inc., The Trustees of the University of Pennsylvania
    Inventors: Ann R. Kennedy, Bernard F. Szuhaj
  • Method of making soybean extract inhibitor
    Patent number: 4793996
    Abstract: In the process of preparing a soybean extract exhibiting inhibition of malignant transformation of cells which comprises defatting soybeans and extracting the inhibitor from the defatted soybeans, the step of defatting the soybeans by bringing them into contact with acetone provides an edible extract of increased effectiveness.
    Type: Grant
    Filed: September 25, 1986
    Date of Patent: December 27, 1988
    Assignee: Ann R. Kennedy
    Inventors: Ann R. Kennedy, Walter Troll, Jonathan Yavelow